Article
Integrative proteomic analysis provides novel therapeutic insights for etiological subtypes of diabetes.
Diabetes, obesity & metabolism - 1 Dec 2025
Wei Jiahe, Wu Hanzhang, Wang Ningjian, Zhu Jiahao, Anjana Ranjit Mohan, Sokolov Aleksandr V, Schiöth Helgi B, Mohan Viswanathan, Tan Xiao
Abstract excerpt
AIMS: Type 2 diabetes (T2D) is a highly heterogeneous disease characterised by subtypes with variations in aetiology, disease progression, and risk of complications. However, potential drug targets for these subtypes have not been explored. This study aims to investigate potential drug targets by integrating proteomics. MATERIALS AND METHODS: Summary-level data of circulating proteins were extracted from the UK...
Read the complete abstract on PubMedTopics
- Humans
- Diabetes Mellitus, Type 2
- Proteomics
- Male
- Female
- Middle Aged
